ATE408602T1 - Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen - Google Patents
Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzenInfo
- Publication number
- ATE408602T1 ATE408602T1 AT02783080T AT02783080T ATE408602T1 AT E408602 T1 ATE408602 T1 AT E408602T1 AT 02783080 T AT02783080 T AT 02783080T AT 02783080 T AT02783080 T AT 02783080T AT E408602 T1 ATE408602 T1 AT E408602T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- monohyroxycarbamezepine
- medication
- manufacture
- neuropathic pain
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 208000035475 disorder Diseases 0.000 title abstract 2
- 208000004296 neuralgia Diseases 0.000 title abstract 2
- 208000021722 neuropathic pain Diseases 0.000 title abstract 2
- 208000017194 Affective disease Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- BMPDWHIDQYTSHX-AWEZNQCLSA-N (S)-MHD Chemical compound C1[C@H](O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 BMPDWHIDQYTSHX-AWEZNQCLSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0127177A GB0127177D0 (en) | 2001-11-12 | 2001-11-12 | Organic compounds |
| GB0127178A GB0127178D0 (en) | 2001-11-12 | 2001-11-12 | Organic compounds |
| GB0127176A GB0127176D0 (en) | 2001-11-12 | 2001-11-12 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE408602T1 true ATE408602T1 (de) | 2008-10-15 |
Family
ID=27256320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02783080T ATE408602T1 (de) | 2001-11-12 | 2002-11-11 | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20050004102A1 (de) |
| EP (2) | EP1446383B1 (de) |
| JP (1) | JP2005511623A (de) |
| KR (1) | KR20050044396A (de) |
| CN (1) | CN100506797C (de) |
| AT (1) | ATE408602T1 (de) |
| AU (2) | AU2007201925B2 (de) |
| BR (1) | BR0214060A (de) |
| CA (1) | CA2463970A1 (de) |
| DE (1) | DE60228988D1 (de) |
| ES (1) | ES2314111T3 (de) |
| HU (1) | HUP0402381A3 (de) |
| IL (1) | IL161700A0 (de) |
| MX (1) | MXPA04004470A (de) |
| NO (1) | NO20041955L (de) |
| NZ (1) | NZ556026A (de) |
| PL (1) | PL368591A1 (de) |
| PT (1) | PT1446383E (de) |
| TW (1) | TW200300090A (de) |
| WO (1) | WO2003042182A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0407569A (pt) * | 2003-02-17 | 2006-02-14 | Novartis Ag | uso de s-10-hidróxi-10, 11-diidro-carbamazepina para o tratamento de ansiendade e distúrbios bipolares |
| GB0303615D0 (en) * | 2003-02-17 | 2003-03-19 | Novartis Ag | Use of organic compounds |
| TW200502222A (en) * | 2003-04-02 | 2005-01-16 | Novartis Ag | Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
| GB0307860D0 (en) * | 2003-04-04 | 2003-05-14 | Novartis Ag | Organic compounds |
| PT2380575E (pt) * | 2005-05-06 | 2015-06-17 | Bial Portela & Ca Sa | Acetato de eslicarbazepina e utilização |
| US20060252745A1 (en) * | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH505101A (de) * | 1969-03-31 | 1971-03-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Azepinderivaten |
| EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
| DK74593D0 (da) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| PT101732B (pt) * | 1995-06-30 | 1997-12-31 | Portela & Ca Sa | Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso |
-
2002
- 2002-11-11 EP EP02783080A patent/EP1446383B1/de not_active Expired - Lifetime
- 2002-11-11 TW TW091133018A patent/TW200300090A/zh unknown
- 2002-11-11 BR BR0214060-8A patent/BR0214060A/pt not_active IP Right Cessation
- 2002-11-11 PL PL02368591A patent/PL368591A1/xx not_active Application Discontinuation
- 2002-11-11 IL IL16170002A patent/IL161700A0/xx unknown
- 2002-11-11 ES ES02783080T patent/ES2314111T3/es not_active Expired - Lifetime
- 2002-11-11 JP JP2003544018A patent/JP2005511623A/ja active Pending
- 2002-11-11 NZ NZ556026A patent/NZ556026A/en not_active IP Right Cessation
- 2002-11-11 WO PCT/EP2002/012578 patent/WO2003042182A1/en not_active Ceased
- 2002-11-11 MX MXPA04004470A patent/MXPA04004470A/es active IP Right Grant
- 2002-11-11 HU HU0402381A patent/HUP0402381A3/hu unknown
- 2002-11-11 AT AT02783080T patent/ATE408602T1/de not_active IP Right Cessation
- 2002-11-11 EP EP08163175A patent/EP2048135A1/de not_active Withdrawn
- 2002-11-11 DE DE60228988T patent/DE60228988D1/de not_active Expired - Lifetime
- 2002-11-11 US US10/494,816 patent/US20050004102A1/en not_active Abandoned
- 2002-11-11 CA CA002463970A patent/CA2463970A1/en not_active Abandoned
- 2002-11-11 KR KR1020047007110A patent/KR20050044396A/ko not_active Ceased
- 2002-11-11 CN CNB028224442A patent/CN100506797C/zh not_active Expired - Fee Related
- 2002-11-11 PT PT02783080T patent/PT1446383E/pt unknown
-
2004
- 2004-05-12 NO NO20041955A patent/NO20041955L/no not_active Application Discontinuation
-
2007
- 2007-05-01 AU AU2007201925A patent/AU2007201925B2/en not_active Ceased
-
2009
- 2009-04-08 AU AU2009201388A patent/AU2009201388A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0402381A3 (en) | 2008-01-28 |
| DE60228988D1 (de) | 2008-10-30 |
| EP1446383B1 (de) | 2008-09-17 |
| HK1068350A1 (en) | 2005-04-29 |
| TW200300090A (en) | 2003-05-16 |
| CN100506797C (zh) | 2009-07-01 |
| HUP0402381A2 (hu) | 2005-03-29 |
| AU2007201925A1 (en) | 2007-05-24 |
| EP2048135A1 (de) | 2009-04-15 |
| NZ556026A (en) | 2008-06-30 |
| AU2007201925B2 (en) | 2009-06-04 |
| IL161700A0 (en) | 2004-09-27 |
| US20050004102A1 (en) | 2005-01-06 |
| MXPA04004470A (es) | 2005-05-16 |
| PT1446383E (pt) | 2008-12-29 |
| EP1446383A1 (de) | 2004-08-18 |
| CA2463970A1 (en) | 2003-05-22 |
| AU2009201388A1 (en) | 2009-05-07 |
| KR20050044396A (ko) | 2005-05-12 |
| BR0214060A (pt) | 2004-10-13 |
| NO20041955L (no) | 2004-05-12 |
| ES2314111T3 (es) | 2009-03-16 |
| PL368591A1 (en) | 2005-04-04 |
| CN1585753A (zh) | 2005-02-23 |
| JP2005511623A (ja) | 2005-04-28 |
| WO2003042182A1 (en) | 2003-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE427114T1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen | |
| DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
| DE69428791D1 (de) | Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden | |
| ATE293976T1 (de) | Verbindungen enthaltend s-tofisopam sowie verwendung dieser verbindungen zur herstellung eines medikamentes zur behandlung oder prophylaxe von krämpfen und anfällen | |
| ATE472329T1 (de) | Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis | |
| DE60205894D1 (de) | 4-(phenyl-piperidin-4-ylidenmethyl)-benzamid-derivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen | |
| ATE408602T1 (de) | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen | |
| BR0306855A (pt) | Método para o tratamento de distúrbios cognitivos | |
| DE60230455D1 (de) | Natürliche verbindung für die behandlung von diabetes, deren herstellung und verwendung | |
| ATE431735T1 (de) | Fusionierte cycloalkyl amid- und carbonsäure- derivate und deren therapeutische verwendung zur behandlung von u.a. epilepsie | |
| DE60128009D1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| ATE464048T1 (de) | Behandlung von alzheimer-krankheit und verwandten zuständen | |
| DE60117122D1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
| ATE247956T1 (de) | Verwendung von modafinil zur herstellung eines arzneimittels zur behandlung von vigilanzstörungen im zusammenhang mit myopathien | |
| MXPA04010816A (es) | Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares. | |
| DE50212649D1 (de) | Verwendung von desoxypeganin zur behandlung der klinischen depression | |
| ATE506947T1 (de) | Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzen | |
| ATE384520T1 (de) | Kombinierte verwendung von einem fibrat und von orlistat zur behandlung von obesitas | |
| DE502004012196D1 (de) | Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen | |
| DE60219495D1 (de) | Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten | |
| ATE318594T1 (de) | Verwendung von treosulfan und derivaten davon zur behandlung der multiplen sklerose | |
| DE50105253D1 (de) | Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis) | |
| BR0206918A (pt) | Uso de iloperidona | |
| DE60108241D1 (de) | Felabamat-derivate zur behandlung von neuropathischem schmerz | |
| DE60022317D1 (de) | Verwendung von fluorierten triazolen zur behandlung von neuropathischem schmerz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1446383 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |